[Strategies for discontinuing immunotherapy in patients with inflammatory bowel disease]
MMW Fortschr Med
.
2021 Apr;163(8):68-71.
doi: 10.1007/s15006-021-9800-3.
[Article in German]
Author
Eduard F Stange
1
Affiliation
1
Klinik für Innere Medizin I, Universitätsklinikum Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland. eduard.stange@icloud.com.
PMID:
33904098
DOI:
10.1007/s15006-021-9800-3
No abstract available
Publication types
Review
MeSH terms
Humans
Immunologic Factors
Immunotherapy
Inflammatory Bowel Diseases* / therapy
Substances
Immunologic Factors